Patent · US Active

Anti-CD38 antibodies and methods of use

US11365261B2 · kind B2 · utility

3Cited by

4References

29Claims

0Family size

Assignee

Sanofi · FR

Inventors

Beatrice Cameron · Paris, FR
Tarik Dabdoubi · Paris, FR
Cendrine Lemoine · Paris, FR
Catherine Prades · Thiais, FR

Key dates

Filing date	Oct 15, 2021
Grant date	Jun 21, 2022
Priority date	—
Expiry date	Oct 15, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/33
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides binding proteins that bind CD38 polypeptides, e.g., human and cynomolgus monkey CD38 polypeptides. For example, the binding proteins can be monospecific, bispecific, or trispecific binding proteins with at least one antigen binding domain that binds a CD38 polypeptide. The disclosure also provides methods for making binding proteins that bind CD38 polypeptides and uses of such binding proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.